TY - JOUR
T1 - Causal Inference in Oncology
T2 - Why, What, How and When
AU - van Amsterdam, W. A.C.
AU - Elias, S.
AU - Ranganath, R.
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2025/2
Y1 - 2025/2
N2 - Oncologists are faced with choosing the best treatment for each patient, based on the available evidence from randomized controlled trials (RCTs) and observational studies. RCTs provide estimates of the average effects of treatments on groups of patients, but they may not apply in many real-world scenarios where for example patients have different characteristics than the RCT participants, or where different treatment variants are considered. Causal inference defines what a treatment effect is and how it may be estimated with RCTs or outside of RCTs with observational – or ‘real-world’ – data. In this review, we introduce the field of causal inference, explain what a treatment effect is and what important challenges are with treatment effect estimation with observational data. We then provide a framework for conducting causal inference studies and describe when in oncology causal inference from observational data may be particularly valuable. Recognizing the strengths and limitations of both RCTs and observational causal inference provides a way for more informed and individualized treatment decision-making in oncology.
AB - Oncologists are faced with choosing the best treatment for each patient, based on the available evidence from randomized controlled trials (RCTs) and observational studies. RCTs provide estimates of the average effects of treatments on groups of patients, but they may not apply in many real-world scenarios where for example patients have different characteristics than the RCT participants, or where different treatment variants are considered. Causal inference defines what a treatment effect is and how it may be estimated with RCTs or outside of RCTs with observational – or ‘real-world’ – data. In this review, we introduce the field of causal inference, explain what a treatment effect is and what important challenges are with treatment effect estimation with observational data. We then provide a framework for conducting causal inference studies and describe when in oncology causal inference from observational data may be particularly valuable. Recognizing the strengths and limitations of both RCTs and observational causal inference provides a way for more informed and individualized treatment decision-making in oncology.
KW - Causal inference
KW - confounding
KW - individualised cancer care
KW - realworld data
KW - research methodology
KW - treatment effect heterogeneity
UR - http://www.scopus.com/inward/record.url?scp=85200886638&partnerID=8YFLogxK
U2 - 10.1016/j.clon.2024.07.002
DO - 10.1016/j.clon.2024.07.002
M3 - Review article
AN - SCOPUS:85200886638
SN - 0936-6555
VL - 38
JO - Clinical Oncology
JF - Clinical Oncology
M1 - 103616
ER -